Calprotectin Testing Market Size 2023 Global Growth, Opportunities, Trends, Effective, Regional Overview, Leading Company Analysis and Forecast to 2031

Reports & Insights has recently released a report titled " Calprotectin Testing Market: Opportunity Analysis and Future Assessment 2023-2031" that emphasizes market-related information, including commercial potential, future opportunities and challenges, current trends, and more in an incredibly meticulous and thorough way. The base year for the study is 2021, and the market size is forecast for the years 2023 through 2031. Additionally, the research contains information about market size, segmentation, and textual & graphical analysis of worldwide market growth patterns during the forecast period of 2023 to 2031.

Reports and Insights predict that the global calprotectin testing market is expected to grow at a CAGR of 6.4% during the forecast period from 2022 to 2030. Furthermore, the total value of the global calprotectin testing market is slated to reach US$ 326.3 Mn by 2030, rising from US$ 198.3 Mn in 2022.

Get Full PDF Sample Copy of Report: https://reportsandinsights.com/sample-request/4279

The degree of intestinal inflammation is determined by a fecal test called calprotectin. Demand for calprotectin testing is booming due to the growing prevalence of cancer and irritable bowel syndrome globally.

The emphasis on at-home testing, which has several benefits including ease of use and diagnosis, is also boosting the sector. These tests can be easily performed in between patient visits if the issue is getting worse and more regular testing is required.

Likewise, the prevalence of IBD and irritable bowel syndrome (IBS) is escalating, which is driving up demand for calprotectin testing and growth in the use of IBD remote monitoring. Active diagnostic testing is therefore more essential for an early diagnosis and successful therapy as a result.

Market Report Outlook:

This report on the global calprotectin testing market aims to discuss market dynamics, including market drivers, potential threats and challenges to the market, global calprotectin testing market opportunities for the major players, global calprotectin testing market trends, market segmentation outlook, regional outlook, global calprotectin testing market size, market forecast, market share, as well as the major players operating in the global calprotectin testing market.

Calprotectin Testing Market: Dynamics

As inflammatory bowel illness becomes more common, the demand for calprotectin testing is anticipated to increase (IBD). Chronic, relapsing, and inflammatory gastric disease is inflammatory bowel disease. The prevalence of Crohn's disease (CD) and ulcerative colitis (UC) is escalating, which will increase market demand. For illustration, according to a 2018 study by the Crohn's and Colitis Foundation of Canada, approximately 27,000 people were living with IBD. By 2030, this figure is predicted to rise to 400,000, representing a 50% increase in the disease's prevalence. According to a different study that was written up in the Journal of Gastroenterology & Hepatology, there were around 6.8 million IBD cases reported worldwide in 2017. The study also concluded that there will be an increase in IBD cases worldwide in the coming years.

Increased calprotectin levels could be a sign of inflammation in the gastrointestinal tract. High levels of calprotectin, however, may not always indicate the presence of IBD. It thus hinders the market from growing during the anticipated period.

These applications for the development of prediction models, precision medicine, epidemiology models, and drug discovery will be advantageous for IBD. Additionally, the utilization of big data in calprotectin testing will create new opportunities for market growth.

View Report Details Before Purchasing - https://reportsandinsights.com/report/calprotectin-testing-market

Calprotectin Testing Market: Regional Outlook

Based on a geographical study, the market for calprotectin testing is segmented into North America, Latin America, Europe, Asia Pacific, the Middle East & Africa, and the Rest of the World.

Throughout the projection period, it is expected that the U.S. will dominate the North American calprotectin testing market size, and this trend is likely to continue.

The demand for calprotectin testing in the UK is being driven by a rise in IBS cases.

Due to an increasing emphasis on the home testing system, China, which currently has the largest share of the East Asian calprotectin testing market forecast, is predicted to grow quickly over the forecast period.

India currently holds a dominant position in the South Asian Calprotectin Testing Market Share, and due to advancements in its diagnostic infrastructure, it is predicted that India will expand at a robust CAGR throughout the projection period.

Some of the key questions answered in this report: 

Which are the five top players of the Calprotectin Testing Market?
How will the Calprotectin Testing Market change in the upcoming years?
Which product and application will take a share of the Calprotectin Testing Market?
What are the drivers and restraints of the Calprotectin Testing Market?
Which regional market will show the highest growth?
What will be the CAGR and size of the Calprotectin Testing Market throughout the forecast period?
What is the current market size, what will the market size be in 2030 and what will the growth rate be?
What are the challenges to grow in the market?
What are the market opportunities and challenges faced by the key vendors?
Who are the major competitors and what is their strategy?
What are the barriers to entry for new players in the market?

Calprotectin Testing Market: Key Players

The prime competitor of the global calprotectin testing market are as follows; Abbexa, AccuBio Tech Co., Ltd., Actim Oy, American Laboratory Products Company, Ltd., Beckman Coulter Inc., Biohit Oyj, Boditech Med Inc., BUHLMANN Laboratories AG, Calpro AS, CerTest Biotec S.L., DiaSorin, DIAsource ImmunoAssays S.A, EagleBio, Elabscience Biotechnology Inc, Epitope Diagnostics, Inc.EUROIMMUN Medizinische Labordiagnostika AG, Hangzhou Biotest Biotech Co., Ltd, R-Biopharm AG., Screen Italia Srl., Thermo Fisher Scientific,  and Vitassay Healthcare, S.L.U. amongst other.

Calprotectin Testing Market: Segmentation Outlook

Data for growth projections and estimates are included in this study for the Test Kits segment (Calprotectin ELISA Test Kits, and Calprotectin Rapid Testing Kits); for the Sample segment (Stool, Blood Serum/Plasma, and Other Biological Samples); for the indication segment (Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Crohn's Disease, and Colorectal Cancer); for the End-User segment (Hospitals, Diagnostic Laboratories, and Specialty Clinics).

To view Top Players, Segmentation and other Statistics of Calprotectin Testing Industry, Get Sample Report @:- https://reportsandinsights.com/sample-request/4279

About Reports and Insights:

Reports and Insights (R&I) is committed to provide deep insights that serve as creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us

Reports and Insights

Tel: +1-(718)-312-8686

For Sales Query: sales@reportsandinsights.com

For New Topics & Other Info, Visit: reportsandinsights.com/

This release was published on openPR.